According to a research report published by UBS, Mengniu management took a more positive approach to the outlook and raised the revenue growth target for the 2026 fiscal year from the number of medium units to the highest number of units. Management said that benefiting from a lower base, stricter cost control and efficiency improvements, the core operating margin is expected to remain at about 8% for the whole year, and the medium- to long-term target is to expand by 30 to 50 basis points each year. Furthermore, the recovery in raw milk prices will support the healthy development of the industry and average price recovery, and capital expenditure is expected to remain below 2 billion yuan for the whole year. UBS raised Mengniu's target price from HK$21.2 to HK$22, reaffirming the “buy” rating.

According to a research report published by UBS, Mengniu management took a more positive approach to the outlook and raised the revenue growth target for the 2026 fiscal year from the number of medium units to the highest number of units. Management said that benefiting from a lower base, stricter cost control and efficiency improvements, the core operating margin is expected to remain at about 8% for the whole year, and the medium- to long-term target is to expand by 30 to 50 basis points each year. Furthermore, the recovery in raw milk prices will support the healthy development of the industry and average price recovery, and capital expenditure is expected to remain below 2 billion yuan for the whole year. UBS raised Mengniu's target price from HK$21.2 to HK$22, reaffirming the “buy” rating.